Related Experiment Video
Updated: May 3, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Implementation of a Novel Patient-Reported Outcome Measure for the Assessment of Symptoms in Children Living With
Banke Oketola1, Karma Abukasm2, Ke Fan Bei3
1University of Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada.
Insights
The PRO-Kid tool effectively measures symptoms in children with chronic kidney disease (CKD), improving communication between patients and providers. Further validation is ongoing to ensure equitable access for diverse pediatric populations.
Area of Science:
- Pediatric Nephrology
- Health Outcomes Research
- Implementation Science
Background:
- Children with chronic kidney disease (CKD) experience significant physical and psychological symptoms.
- Patient-reported outcome (PRO) measurement tools are crucial for quantifying symptoms and enhancing communication.
- The PRO-Kid tool was developed to address these needs in pediatric CKD populations.
Purpose of the Study:
- To implement the novel PRO-Kid tool into pediatric CKD and dialysis programs across Canada.
- To assess organizational readiness for PRO tool implementation.
- To evaluate implementation outcomes using established frameworks.
Main Methods:
- The PRO-Kid tool, a 14-item questionnaire for ages 8-18, was implemented in seven Canadian Pediatric Nephrology Programs.
- Organizational readiness was assessed using the Consolidated Framework for Implementation Research (CFIR).
- Implementation outcomes were evaluated using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework through audits, surveys, and focus groups.
Main Results:
- The PRO-Kid tool demonstrated strong internal consistency and validity (Cronbach's alpha > .83).
- Preliminary evaluations indicate the tool is easy to use and satisfactory for both patients and healthcare providers.
- Key facilitators include local champions, while barriers include language, low reading levels, and clinical staff availability.
Conclusions:
- The PRO-Kid tool can improve communication and symptom identification in pediatric CKD care.
- Ongoing validation of different age versions and translations will ensure broader applicability and equitable access.
- Integration into clinical settings requires active roles from local teams for successful adoption and sustainability.
Purpose Of The Program:
Children with chronic kidney disease (CKD) experience significant physical and psychological symptoms, necessitating patient-reported outcome (PRO) measurement tools to quantify symptoms, and to improve communication between children with CKD and their health care providers. This study aimed to implement the novel PRO-Kid tool into pediatric CKD and dialysis programs in Canada.
Sources Of Information:
The PRO-Kid tool is a novel 14-item questionnaire that was developed and validated by our research team, in partnership with patients living with childhood-onset CKD and caregivers for children with G3-G5 CKD, including dialysis. PRO-Kid measures both the frequency and impact of CKD symptoms in children ages eight to 18 years. It showed strong internal consistency and validity, as demonstrated by a Cronbach alpha of .83 (95% confidence interval [CI], 0.78-0.88) for the frequency scale, and .84 (95% CI, 0.80-0.89) on the impact scale.
Methods:
The PRO-Kid tool is being implemented in seven Pediatric Nephrology Programs across Canada. Guided by the Consolidated Framework for Implementation Research (CFIR), organizational readiness at each of the sites was assessed via surveys and focus groups. To date, the PRO-Kid tool (eight- to 18-year-old version) and site-specific toolkits have been implemented at three sites that were ready to launch (HSC, Winnipeg; BC Children's Hospital, Vancouver; and McMaster Children's Hospital, Hamilton). Implementation outcomes, such as the number of patients reached and patient and provider satisfaction, were evaluated using audits, surveys, and focus groups guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.
Key Findings:
The organizational readiness assessment identified different electronic medical records and preferences for paper-based data collection methods across sites as well as the need to translate the PRO-Kid tool into other languages. Preliminary evaluation revealed that PRO-Kid is easy to use and is satisfactory to both patients and health care providers. Local champions were identified as key facilitators of implementation efforts. PRO-Kid can help improve communication between children with CKD and their health care providers in identifying symptoms that may not otherwise come up (be disclosed) during clinical encounters. However, language and low reading levels are barriers for some children, and unavailability of clinical staff can limit the use of the tool at some sites.
Implications:
Local teams will be required to play crucial roles in integrating the use of the tool in clinical settings. To ensure the tool can be applied across diverse populations, the validation of PRO-Kid tool two to four years old, five to seven years old, and French versions are ongoing. The availability of different versions of the tool will ensure equitable access and promote sustainability of the tool.
Related Concept Videos
Data Reporting and Recording
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Nursing Evaluation
Methods of Documentation II: POMR
Methods of Documentation III: PIE
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

